The Forward-ME Group have issued a statement calling on NHS England to urge caution in use of GET immediately in light of its highly probable removal as a ‘treatment’ in the April 2021 guideline.
You can read the full statement here –
Need for action now to ensure safe NHS care and management advice for Myalgic Encephalomyelitis (ME) patients
